Syneos Health to Host Virtual Analyst and Investor Event on December 8, 2020
Syneos Health (Nasdaq:SYNH) announced it will host an Analyst and Investor Event on December 8, 2020, from 9:00 a.m. to 11:30 a.m. EST.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Syneos Health (Nasdaq:SYNH) announced it will host an Analyst and Investor Event on December 8, 2020, from 9:00 a.m. to 11:30 a.m. EST. The virtual event will feature presentations from company leadership detailing their unique product development model and plans for growth in the healthcare sector. The event will be accessible via a live webcast on the company's Investor Relations website, featuring audio, video, and presentation materials. The aim is to enhance communication with investors and showcase Syneos' integrated solutions for biopharmaceutical development.
Details
News Market Reaction – SYNH
The recorded move for SYNH in the trading session of this news was +1.09%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MORRISVILLE, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), will host an Analyst and Investor Event on Tuesday, December 8, 2020, from 9:00 a.m. to approximately 11:30 a.m. EST.
The event, to be held virtually, will include presentations from Syneos Health leadership about the Company’s unique product development model and plan to drive accelerated growth in the evolving healthcare environment.
A live webcast, including audio, video, presentation materials and an archived replay, will be available on the Company’s Investor Relations website at investor.syneoshealth.com. Participants can pre-register and also access the webcast directly at SyneosHealthInvestorDay.com.
About Syneos Health
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
| Contacts | |
| Investor Relations: | Press/Media: |
| Ronnie Speight | Danielle DeForge |
| Senior Vice President, Investor Relations | Vice President, External Communications |
| +1 919 745 2745 | +1 202 210 5992 |
| Investor.Relations@syneoshealth.com | danielle.deforge@syneoshealth.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.